Title : Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist.

Pub. Date : 2011 Mar

PMID : 21473737






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Suvorexant (MK-4305) is a potent, selective, and orally bioavailable antagonist of OX(1)R and OX(2)R currently under clinical investigation as a novel therapy for insomnia. suvorexant hypocretin receptor 2 Rattus norvegicus
2 Suvorexant (MK-4305) is a potent, selective, and orally bioavailable antagonist of OX(1)R and OX(2)R currently under clinical investigation as a novel therapy for insomnia. suvorexant hypocretin receptor 2 Rattus norvegicus